Considering BDNF’s role in neuronal functions together with RSG’s attenuation of AD-related pathologies and modulation of BDNF, this review explores the possibility that RSG’s benefits in pre-clinical models of AD are due at least in part to its ability to enhance BDNF expression and signaling. Here, BDNF is linked to Alzheimer disease.